Pfizer vaccine. AFP=Yonhap News
On the 27th, in Korea, the new coronavirus infection (Corona 19) vaccine developed by Pfizer will begin. In Israel, which has the fastest vaccination rate, less than 0.3% of them experienced adverse reactions after receiving the Pfizer vaccine.
According to the Centers for Disease Control and Prevention (Bang Dae-bon) on the 27th, immunizations will begin at 9 am on the 27th at the Central Vaccination Center in Seoul to 199 workers at the National Medical Center and 101 workers at the treatment hospital for corona19 patients in the metropolitan area. In the COVID-19 vaccination special briefing, which was held on the 24th, Chung Eun-kyung said, “It is a common adverse reaction of the COVID-19 vaccination reported in each country. It is a mild reaction that occurs within 1 to 2 days after vaccination and disappears within a few days.”
According to reports from countries around the world that first started vaccination, 1893360 people in the United States received the Pfizer vaccine as of December 23rd last year, of which 0.1% or 4393 cases of adverse reactions were reported. Severe adverse reactions were reported in 175 cases, or 0.005%. Anaphylaxis reaction (in vivo hypersensitivity reaction caused by antigen-antibody reaction) occurred in 21 cases in 0.0005%.
In Germany, 2,432,766 people received the Pfizer vaccine, of which 0.12% or 2717 adverse reactions were reported. There were 337 serious adverse reactions, 0.014%, and there was no data related to anaphylaxis.
Pfizer vaccination is also being done in Norway, Canada and France. Although the exact number of vaccinations has not yet been released, the rate of reporting adverse reactions was about 0.06% to 0.12%.
Israeli Prime Minister Benjamin Netanyahu received the Corona 19 vaccine at the Shiva Medical Center in Tel Aviv on the 9th of last month. It was the second dose of the Pfizer vaccine. Central photo
In Israel, which has the fastest vaccination rate in the world, less than 0.3% of people received the Pfizer vaccine and reported adverse reactions. According to the results of a survey released by the Israeli Ministry of Health on the 2nd (local time), a total of 6575 side effects were reported as a result of a survey of 2.78,200 people who completed the first vaccination, the incidence rate was 0.24%, and out of 1,377827 second inoculations. The number of people who complained of side effects was 3592, a ratio of 0.26%.
The Israeli Ministry of Health said that the adverse reaction to the vaccine was “light or passed quickly”. “After the first vaccination, the number of hospitalized treatments as a side effect was only 17 per 1 million, and only 3 per 1 million in the case of the second vaccination.” .
How to get Pfizer vaccination. Graphic = Reporter Kim Young-ok [email protected]
Of the adverse reactions reported after the first dose in Israel, about 50% were pain in the arm area, and 41% felt a mild feeling, indicating that they were not feeling well. In the case of the second inoculation, 22% complained of pain in the arm and 77% complained of feeling unwell. Neurological sequelae was reported in 287 cases for the first vaccination and 96 cases for the second vaccination. Allergic reactions including anaphylaxis were 165 cases after the first vaccination and 47 cases after the second vaccination. Other adverse reactions were 60 cases after the first inoculation and 19 cases after the second inoculation.
Corona 19 vaccination adverse reaction response. Graphic = Kim Hyun-seo [email protected]
According to data from clinical trials related to emergency approval of Pfizer’s vaccine in the U.S. and UK, released by the quarantine authorities in January, the most common adverse reaction was pain at the vaccination site (84.1%) as a result of observing 43,448 participants in clinical trials over 16 years old. Then, fatigue (62.9%), headache (55.1%), muscle pain (38.3%), chills (31.9%), and joint pain (23.6%) were followed.
A study found that the Pfizer vaccine was 94% effective. On the 14th (local time), the largest health institution in Israel, Clarit said, “The infection rate of 600,000 people who received the vaccine was 94% lower than those who did not, and the probability of getting severe illness was reduced by 92%.” Previously, Pfizer announced that it had a 95% antibody formation rate as a result of a large-scale phase 3 clinical trial.
Reporter Lee Tae-yoon [email protected]
